药物对比
Ubrogepant vs Zolmitriptan
比较 Ubrogepant (Ubrelvy) 与 Zolmitriptan (Zomig) 用于急性偏头痛治疗。Ubrogepant 为 CGRP 受体拮抗剂，无血管收缩作用，而 Zolmitriptan 为 5‑羟色胺激动剂（triptan）。两者均为口服处方药，适用于不同患者特征，尤其在心血管风险方面。
此页面暂无可用的对比维度。
临床背景
Patients experiencing acute migraines who do not respond adequately to triptans or have contraindications to vasoconstrictive agents may trigger this comparison.
结论
Both Ubrogepant and Zolmitriptan are effective oral treatments for acute migraine relief, with the best option varying by patient needs.
全部药物对比